Maryland Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Maryland Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$466K	Hold	3,530	–	–	0.04%	150
2022 Q2	$479K	Sell	3,530 -270	-7%	-$37.2K	0.04%	148
2022 Q1	$567K	Sell	3,800 -110	-3%	-$16.3K	0.04%	152
2021 Q4	$633K	Hold	3,910	–	–	0.03%	149
2021 Q3	$649K	Buy	+3,910	New	+$668K	0.04%	144
2021 Q2	–	Sell	-4,160	Closed	-$668K	–	259
2021 Q1	$668K	Buy	+4,160	New	+$712K	0.04%	136
2020 Q4	–	Sell	-4,360	Closed	-$686K	–	226
2020 Q3	$686K	Buy	+4,360	New	+$713K	0.06%	115
2020 Q2	–	Sell	-4,210	Closed	-$552K	–	201
2020 Q1	$552K	Buy	+4,210	New	+$600K	0.07%	120

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Maryland Capital Management's FBT Position: Q3 2022 in Review

Maryland Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2022 at 3,530 shares worth $466K. The position accounts for 0.04% of the portfolio, ranked #150.

Maryland Capital Management first reported a position in FBT in Q1 2020 and has held it in 8 quarters since. The position peaked at $686K in Q3 2020. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

Maryland Capital Management held 3,530 shares of First Trust NYSE Arca Biotechnology Index Fund worth $466K as of Q3 2022.
Maryland Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2022.
First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Maryland Capital Management's portfolio in Q3 2022, its #150 holding.
Maryland Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2020 and has held it in 8 quarters since.
Maryland Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $686K in Q3 2020.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.